The effect of two novel lubricant eye drops on tear film lipid layer thickness in subjects with dry eye symptoms.
OBJECTIVE
Because the lipid layer of the tear film is recognized as a critical component in dry eye disease, this study was designed to determine if a single eye drop of either Soothe or Systane produces a significant increase in lipid layer thickness (LLT) for subjects reporting symptoms indicative of dry eyes.


METHODS
A double-blind, internally paired study was performed. A custom-built lipid layer interferometer, enabling characterization of lipid layer interference patterns, was used to quantify baseline LLT (OU) of eligible subjects. Inclusion criteria included: 1) presence of dry eye symptoms and 2) baseline LLT < or =75 nm. Subjects (n = 40) received a single eye drop of Soothe in one eye and a single eye drop of Systane in the contralateral eye. After the instillation of each test drop, LLT was reanalyzed for all subjects.


RESULTS
The mean +/- standard error baseline LLT pre-eye drop instillation was 60.0 +/- 1.8 nm for eyes treated with Soothe and 61.5 +/- 1.8 nm for eyes treated with Systane. These means were not significantly different (p > 0.5). The mean LLT for eyes treated with Soothe increased to 124.4 +/- 4.9 nm (p < 0.0001). The mean LLT for eyes treated with Systane increased to 71.3 +/- 2.6 nm (p < 0.0001). The LLT increase from Soothe was significantly greater than that from Systane (p < 0.0001).


CONCLUSIONS
In subjects with symptoms indicative of dry eye states and LLT < or =75 nm, one eye drop of Soothe more than doubled LLT, a 107% mean increase, whereas Systane increased LLT by 16%.
Korb
Donald R
DR
Korb Associates, Boston, MA 02116, USA. drkorb@aol.com
Scaffidi
Robert C
RC
Greiner
Jack V
JV
Kenyon
Kenneth R
KR
Herman
John P
JP
Blackie
Caroline A
CA
Glonek
Thomas
T
Case
Courtney L
CL
Finnemore
Victor M
VM
Douglass
Teresa
T
D000328:Adult; D000368:Aged; D004311:Double-Blind Method; D015352:Dry Eye Syndromes / Q000188:drug therapy / Q000378:metabolism*; D004643:Emollients / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D007368:Interferometry; D050356:Lipid Metabolism; D008153:Lubrication; D008297:Male; D008875:Middle Aged; D009883:Ophthalmic Solutions / Q000008:administration & dosage*; D013666:Tears / Q000378:metabolism*; D017155:Wettability
D004643:Emollients; D009883:Ophthalmic Solutions